{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T10:51:09Z","timestamp":1778410269336,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI061093"],"award-info":[{"award-number":["AI061093"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["K23AI115001"],"award-info":[{"award-number":["K23AI115001"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR000142"],"award-info":[{"award-number":["UL1 TR000142"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007503","name":"T.C. \u0130stanbul K\u00fclt\u00fcr \u00dcniversitesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007503","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["K12HD0141401-10"],"award-info":[{"award-number":["K12HD0141401-10"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.jaci.2015.05.012","type":"journal-article","created":{"date-parts":[[2015,6,19]],"date-time":"2015-06-19T05:31:14Z","timestamp":1434691874000},"page":"1315-1325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["TNF receptor superfamily member 13b (TNFRSF13B) hemizygosity reveals transmembrane activator and CAML interactor haploinsufficiency at later stages of B-cell development"],"prefix":"10.1016","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1881-5318","authenticated-orcid":false,"given":"Neil","family":"Romberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manmeet","family":"Virdee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Chamberlain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7178-7822","authenticated-orcid":false,"given":"Tyler","family":"Oe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Nicolas","family":"Schickel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiffany","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tineke","family":"Cantaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rima","family":"Rachid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Rosengren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina","family":"Palazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raif","family":"Geha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Cunningham-Rundles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Meffre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2015.05.012_bib1","first-page":"162","article-title":"Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency","volume":"5","author":"Al-Herz","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2015.05.012_bib2","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1182\/blood-2008-02-141937","article-title":"Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes","volume":"113","author":"Salzer","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2015.05.012_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/blood-2010-01-254417","article-title":"How I treat common variable immune deficiency","volume":"116","author":"Cunningham-Rundles","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2015.05.012_bib4","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jaci.2007.10.001","article-title":"Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes","volume":"120","author":"Zhang","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2015.05.012_bib5","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1172\/JCI69854","article-title":"CVID-associated TACI mutations affect autoreactive B cell selection and activation","volume":"123","author":"Romberg","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2015.05.012_bib6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.20032000","article-title":"TACI and BAFF-R mediate isotype switching in B cells","volume":"201","author":"Castigli","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2015.05.012_bib7","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/ni829","article-title":"DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL","volume":"3","author":"Litinskiy","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2015.05.012_bib8","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.jaci.2007.06.012","article-title":"Transmembrane\u00a0activator and calcium modulator and cyclophilin ligand interactor enhances CD40-driven plasma cell differentiation","volume":"120","author":"Castigli","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2015.05.012_bib9","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/eji.200636800","article-title":"Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion","volume":"37","author":"Katsenelson","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2015.05.012_bib10","doi-asserted-by":"crossref","first-page":"35478","DOI":"10.1074\/jbc.M005224200","article-title":"Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS","volume":"275","author":"Wu","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2015.05.012_bib11","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/ni.1914","article-title":"The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88","volume":"11","author":"He","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2015.05.012_bib12","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.jaci.2010.08.017","article-title":"The C104R mutant impairs the function of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) through haploinsufficiency","volume":"126","author":"Lee","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2015.05.012_bib13","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1172\/JCI31023","article-title":"Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID)","volume":"117","author":"Garibyan","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2015.05.012_bib14","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1182\/blood-2008-11-189720","article-title":"The murine equivalent of the A181E TACI mutation associated with common variable immunodeficiency severely impairs B-cell function","volume":"114","author":"Lee","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2015.05.012_bib15","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/ng1600","article-title":"Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans","volume":"37","author":"Salzer","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2015.05.012_bib16","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/ng1601","article-title":"TACI is mutant in common variable immunodeficiency and IgA deficiency","volume":"37","author":"Castigli","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2015.05.012_bib17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/sj.ejhg.5202009","article-title":"Smith-Magenis syndrome","volume":"16","author":"Elsea","year":"2008","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jaci.2015.05.012_bib18","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.jaci.2011.02.046","article-title":"Transmembrane activator and CAML interactor (TACI) haploinsufficiency results in B-cell dysfunction in patients with Smith-Magenis syndrome","volume":"127","author":"Chinen","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2015.05.012_bib19","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1126\/science.1086907","article-title":"Predominant autoantibody production by early human B cell precursors","volume":"301","author":"Wardemann","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jaci.2015.05.012_bib20","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/clim.1999.4799","article-title":"Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies)","volume":"93","author":"Conley","year":"1999","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2015.05.012_bib21","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1084\/jem.20040920","article-title":"Bruton's tyrosine kinase (Btk) is essential for human B cell tolerance","volume":"200","author":"Ng","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2015.05.012_bib22","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.immuni.2008.09.015","article-title":"IRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans","volume":"29","author":"Isnardi","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2015.05.012_bib23","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1172\/JCI61788","article-title":"Defective B cell tolerance in adenosine deaminase deficiency is corrected by gene therapy","volume":"122","author":"Sauer","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2015.05.012_bib24","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jaci.2012.10.029","article-title":"TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes","volume":"131","author":"Martinez-Gallo","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2015.05.012_bib25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","article-title":"The EUROclass trial: defining subgroups in common variable immunodeficiency","volume":"111","author":"Wehr","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2015.05.012_bib26","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1084\/jem.20062287","article-title":"CD40 ligand and MHC class II expression are essential for human peripheral B\u00a0cell tolerance","volume":"204","author":"Herve","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2015.05.012_bib27","doi-asserted-by":"crossref","first-page":"11554","DOI":"10.1073\/pnas.1102600108","article-title":"Activation-induced cytidine deaminase (AID) is required for B-cell tolerance in humans","volume":"108","author":"Meyers","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2015.05.012_bib28","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jaci.2014.07.042","article-title":"Dedicator of cytokinesis 8-deficient patients have a breakdown in peripheral B-cell tolerance and defective regulatory T cells","volume":"134","author":"Janssen","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2015.05.012_bib29","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s10875-009-9351-3","article-title":"Frequency of Treg cells is reduced in CVID patients with autoimmunity and splenomegaly and is associated with expanded CD21lo B lymphocytes","volume":"30","author":"Arumugakani","year":"2010","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2015.05.012_bib30","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.clim.2007.04.012","article-title":"High serum levels of BAFF, APRIL, and TACI in common variable immunodeficiency","volume":"124","author":"Knight","year":"2007","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2015.05.012_bib31","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.clim.2008.12.006","article-title":"Regulatory T cell dysfunction in subjects with common variable immunodeficiency complicated by autoimmune disease","volume":"131","author":"Yu","year":"2009","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2015.05.012_bib32","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.immuni.2010.12.012","article-title":"Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion","volume":"34","author":"Morita","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2015.05.012_bib33","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1126\/science.1176676","article-title":"Bcl6 mediates the development of T follicular helper cells","volume":"325","author":"Nurieva","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.jaci.2015.05.012_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2011.06347.x","article-title":"The establishment of early B cell tolerance in humans: lessons from primary immunodeficiency diseases","volume":"1246","author":"Meffre","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaci.2015.05.012_bib35","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1182\/blood-2012-09-457465","article-title":"Accumulation of peripheral autoreactive B cells in the absence of functional human regulatory T cells","volume":"121","author":"Kinnunen","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2015.05.012_bib36","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1182\/blood-2011-05-353961","article-title":"TACI deficiency impairs sustained Blimp-1 expression in B cells decreasing long-lived plasma cells in the bone marrow","volume":"118","author":"Tsuji","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2015.05.012_bib37","doi-asserted-by":"crossref","first-page":"15401","DOI":"10.1073\/pnas.1200386109","article-title":"Deficiency in TNFRSF13B (TACI) expands T-follicular helper and germinal center B cells via increased ICOS-ligand expression but impairs plasma cell survival","volume":"109","author":"Ou","year":"2012","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674915007162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674915007162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T15:01:58Z","timestamp":1777474918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674915007162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0091674915007162"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2015.05.012","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TNF receptor superfamily member 13b (TNFRSF13B) hemizygosity reveals transmembrane activator and CAML interactor haploinsufficiency at later stages of B-cell development","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2015.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}